Skip to main content
INMB logo

INMB · Inmune Bio, Inc. · Executive Compensation

Track INMB — free
$0.89 0.00 (-0.47%) Play latest call Q3 2026 earnings call transcript
Market Cap
$27.68M
Shares
30.96M
Volume · Nov 20 7246 Avg daily vol (3M) 342.92K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Raymond J. Tesi $2,849,504
David J. Moss $1,845,179
Mark Lowdell $1,452,236
Cory Ellspermann $619,227
Fiscal 2024
Executive Total
Raymond J. Tesi $3,008,174
David J. Moss $2,722,003
Mark Lowdell $1,792,412
Fiscal 2023
Executive Total
Raymond J. Tesi $1,694,818
David J. Moss $1,589,218
Mark Lowdell $150,237
Fiscal 2022
Executive Total
Raymond J. Tesi $1,444,509
David J. Moss $1,298,169
Mark Lowdell $904,599
Fiscal 2021
Executive Total
Raymond J. Tesi $2,702,228
David J. Moss $2,631,228
Mark Lowdell $149,478
Fiscal 2020
Executive Total
David J. Moss $300,000
Raymond J. Tesi $300,000
Mark Lowdell $138,204

Executive changes

Person Change Filed
James Sapirstein Appointed 2026-09-14
James Sapirstein Appointed 2026-09-14
R. Duane Clark II Appointed 2026-09-14
R. Duane Clark II Appointed 2026-09-14
Scott Juda, JD Appointed 2026-06-17
Marcia Allen Already on the board
Since at least 2019: re-election or new board role
2026-06-17
Tim Schroeder Already on the board
Since at least 2016: re-election or new board role
2026-06-17
J. Kelly Ganjei Already on the board
Since at least 2016: re-election or new board role
2026-06-17
David Moss Appointed 2026-06-17
Cory Ellspermann Appointed 2025-11-28
Marcia Allen Already on the board
Since at least 2019: re-election or new board role
2025-06-10
Tim Schroeder Already on the board
Since at least 2016: re-election or new board role
2025-06-10
Scott Juda, JD Appointed 2025-06-10
J. Kelly Ganjei Already on the board
Since at least 2016: re-election or new board role
2025-06-10
Raymond J. Tesi, MD Appointed 2025-06-10
Edgardo Baracchini
“Mr. Baracchini’s resignation was not the result of any disagreement relating to the Company’s policies, operations or practices.”
Resigned 2024-07-05
Marcia Allen Already on the board
Since at least 2019: re-election or new board role
2023-06-01
Edgardo Baracchini, PhD Appointed 2023-06-01
Scott Juda, JD Appointed 2023-06-01
Tim Schroeder Already on the board
Since at least 2016: re-election or new board role
2023-06-01
J. Kelly Ganjei Already on the board
Since at least 2016: re-election or new board role
2023-06-01
Raymond J. Tesi, MD Appointed 2023-06-01
David Szymkowski, Ph.D.
“Mr. Szymkowski did not advise the Company of any disagreement with the Company on any matter relating to its operations, policies or practices.”
Resigned 2021-06-15
David Szymkowski
“Mr. Szymkowski did not advise the Company of any disagreement with the Company on any matter relating to its operations, policies or practices.”
Resigned 2021-06-15

Leadership

Key facts CIK 1711754 CUSIP 45782T105 13F (30d) 70 filings 58 filers Visit website Investor relations